http://hyper.ahajournals.org/content/64/4/897.long
A Systematic Review and Meta-Analysis of Randomized, Controlled Trials
Abstract
Previous human clinical trials have shown that probiotic
consumption may improve blood pressure (BP) control. The aim of the
present systematic review was to clarify the effects of probiotics on BP
using a meta-analysis of randomized, controlled trials. PubMed, Scopus,
Cochrane Library (Central), Physiotherapy Evidence Database, and
Clinicaltrial.gov databases were searched until January 2014 to identify
eligible articles. Meta-analysis using a random-effects model was
chosen to analyze the impact of combined trials. Nine trials were
included. Probiotic consumption significantly changed systolic BP by
−3.56 mm Hg (95% confidence interval, −6.46 to −0.66) and diastolic BP
by −2.38 mm Hg (95% confidence interval, −2.38 to −0.93) compared with
control groups. A greater reduction was found with multiple as compared
with single species of probiotics, for both systolic and diastolic BP.
Subgroup analysis of trials with baseline BP ≥130/85 mm Hg compared with
<130/85 mm Hg found a more significant improvement in diastolic BP.
Duration of intervention <8 weeks did not result in a significant
reduction in systolic or diastolic BP. Furthermore, subgroup analysis of
trials with daily dose of probiotics <1011 colony-forming
units did not result in a significant meta-analysis effect. The present
meta-analysis suggests that consuming probiotics may improve BP by a
modest degree, with a potentially greater effect when baseline BP is
elevated, multiple species of probiotics are consumed, the duration of
intervention is ≥8 weeks, or daily consumption dose is ≥1011 colony-forming units.
Introduction
Blood pressure (BP) has been strongly and positively
associated with the risk of chronic diseases, including ischemic heart
disease, heart failure, stroke, and kidney disease.1,2
BP can be controlled through diet and lifestyle modification to prevent
hypertension (systolic BP [SBP] ≥140 mm Hg or diastolic BP [DBP] ≥90 mm
Hg) or related complications.3 Evidence suggests that low-fat diets rich in fruits and vegetables and low in sodium can lower BP.4–6 Previous studies have also found that dietary constituents and supplements such as omega-3 fatty acids,7 garlic,8 and green tea9,10 can improve BP control.
In recent years, the health benefits of probiotics have
attracted increased attention. Probiotics are defined as live
microorganisms that may have health benefits for the host if consumed in
adequate amounts.11 Probiotics are well studied for their health benefits in improving immune system function12 and preventing diarrhea.13,14
It has also been demonstrated that probiotics and their products can
improve BP through mechanisms including improving total cholesterol and
low-density lipoprotein cholesterol levels,15–17 reducing blood glucose level and insulin resistance,18,19 and regulating the renin–angiotensin system.20,21
A recent systematic review and meta-analysis of 14
randomized, controlled trials showed that consumption of fermented milk
containing inhibitory peptides (with or without probiotics) can
significantly reduce SBP and DBP.22
However, the effects of probiotics (live bacteria) and their species or
dose were not systematically investigated. Some previous studies on
probiotics have reported that consumption of probiotic yogurt for 8
weeks can significantly improve BP,23,24 whereas another study showed no benefit.25
Because of inconclusive reports on the effect of probiotics on BP and
lack of information on effective intervention characteristics, the
current systematic review and meta-analysis of randomized, controlled
trials has been conducted. The findings from this meta-analysis may
provide further information on the effective probiotic species, duration
or dose of consumption required to confer health, and BP benefits.
No comments:
Post a Comment